|To: TokyoMex who wrote ()||2/10/2000 9:27:00 AM|
Casino Journal and Players Network Create In-Depth Multi-Media Marketing Alliance|
Alliance Delivers a Broad Range of Entertainment and Information to Casino Players
Alliance Produces a New Line of Gambling Videos Under the Casino Journal Banner
LAS VEGAS, Feb. 10 /PRNewswire/ -- Casino Journal Publishing Group, Inc. (OTC Bulletin Board: CJPG) and Players Network (OTC Bulletin Board: PNTV) today announced a multi-faceted alliance between the two companies. The alliance will encompass Internet, Television and Print Advertising along with traditional video to both promote the two companies and educate gamblers.
The terms of the alliance are as follows:
Players Network has completed production of a line of 6 educational video tapes for Casino Journal Publishing Group. The video tapes focus on video poker and slot machines and utilize the talent and knowledge of experts Bob Dancer and Jeffrey Compton. Dancer and Compton are Video Poker and Slot Club Editors of CJPG's Casino Player and Strictly Slots magazines. The videos educate gamblers on slot clubs, slot machines and strategies on playing the different kind of video poker machines which are currently on the market. The videos are marketed for sale in Casino Player and Strictly Slots magazines and via CJPG's on-line Dealer's Choice Gift Shop at www.casinocenter.com.
Players Network has the rights to utilize excerpts of the CJPG video tapes on their Players Network closed circuit television network and on their PlayersNetwork.com gaming and entertainment Internet portal. Casino Journal Publishing Group will market PlayersNetwork.com via Casino Player and Strictly Slots magazine. Players Network will market Casino Journal publications on PlayersNetwork.com.
Players Network has also begun producing a commercial for CJPG's Casino Player and Strictly Slots magazines. This commercial will be aired on the Players Network closed circuit television network and on PlayersNetwork.com. Casino Journal will utilize the commercial for future marketing venues with plans to advertise on national television and cable networks. Casino Journal has also begun contributing content for PlayersNetwork.com, creating a multi-faceted relationship.
Players Network and Casino Journal Publishing Group, Inc. have enjoyed a working relationship since the formation of Players Network. Casino Journal subsidiary, Gaming Venture Corp. U.S.A., assisted in the formation and startup of the Players Network television network in 1995. Casino Journal and Players Network entered into various marketing and consulting contracts prior to the formation of this multi-media alliance. Casino Journal Publishing Group is one of the largest, non-insider shareholders of Players Network.
Commenting on the alliance, Casino Journal Chairman, CEO and Group Publisher, Glenn Fine said, "This alliance with Players Network has helped the Company accomplish another one of our goals. We have realized that with the audience our publications have, we should begin producing products under the Casino Player and Strictly Slots banners. These 6 videos by Bob Dancer and Jeff Compton, two of our top writers and the foremost experts in the field of video poker and slot clubs, have already received a great response from our readers. We expect to expand the market for these videos to gift shops in casinos across the United States as well as on other E-commerce areas on the Internet. The commercial Players Network is producing will be an integral part of future marketing programs for the Company. We look forward to continuing the relationship which has been ongoing for 5 years now."
Mark Bradley, President of Players Network added, "The alliance with Casino Journal Publishing Group shows that both companies are taking a very aggressive stance, positioning ourselves to lead the industry in new media and exciting content. The result of this alliance is the convergence of the most exciting aspects of the media industry: Internet, television, print, traditional video content and advertising. This multi-million dollar alliance benefits both companies as Casino Journal expands into the video market and gets an advertising venue which they never had before and Players Network receives exposure and content for PlayersNetwork.com and the Players Network television network. We both feel that this is a win-win alliance for both parties."
Casino Journal Publishing Group, Inc. publishes Casino Journal, the company's flagship magazine, and the most widely read trade publication serving the gaming industry; the National Gaming Summary, an extensive weekly newsletter that provides up-to-the-minute gaming news; the Gaming Industry Weekly and Daily Reports and the Daily Lodging Report, targeting gaming and lodging executives and investors. For the gaming consumer, CJPG publishes Casino Player and Strictly Slots, the nation's largest circulation consumer gaming publications, and the Atlantic City Insider, which targets the frequent Atlantic City gambler. The Company also produces the American Gaming, Lodging and Leisure Summit in conjunction with Bear Stearns & Co. and the law firm of Lionel Sawyer and Collins; the Southern Gaming Summit with the Mississippi Casino Operators Association; the Atlantic City Chamber of Commerce Business Expo, the Northern Gaming Summit in conjunction with the Michigan law firm of Fraser Trebilcock Davis & Foster and Bear Stearns & Co. and UNLV Casino Ops trade shows.
Players Network owns and operates PlayersNetwork.com, a gaming and entertainment Internet Portal which combines content, e-commerce and video on the World Wide Web. Players Network is the first and only digital 24-hour gaming and entertainment network which specializes in producing customized television programming to serve the rapidly growing gaming industry. Players Network delivers its 24-hour television channel directly into hotel and casino guestrooms and on the Internet. The Company's format is designed to educate new players and promote casino games and activities. With 180 million people per year visiting U.S. casinos, the industry is now the largest form of participant entertainment in the world. Programming includes shows on basic gaming instruction, news, sports and racing, entertainment and tournaments.
SOURCE: Casino Journal Publishing Group, Inc.
CONTACT: Alan Woinski of Casino Journal Publishing Group, 201-599-8484; or Mark Bradley of Players Network, 702-895-8884
|RecommendKeepReplyMark as Last Read|
|To: TokyoMex who wrote ()||2/10/2000 10:42:00 PM|
Football Network To Attend Toyota/Dan Marino Celebrity Golf Invitational |
FORT LAUDERDALE, Fla.--(BW SportsWire)--Feb. 9, 2000--TFN, The Football Network, Inc., (OTC BB: TFNK), has announced that it will attend the ninth annual Dan Marino golf tournament sponsored by Toyota.
The event, which has raised millions of dollars for various youth charities chosen by the Dan Marino Foundation, distributes the proceeds throughout the South Florida area.
The four-day event held at the Weston Hills Country Club in Ft. Lauderdale, Florida will begin on February 17th with a pairing party and silent auction. TFN has donated two network letterman jackets to the auction, which will be autographed by Dan Marino and other NFL quarterback icons. TFN President Jantonio Turner will attend the celebrity/amateur event held on the 18th of February. Billy Joel, Marcus Allen, Doug Flutie, Jason Sehorn, D.B. Sweeney, Ivan Lendl, Hootie and the Blowfish, WWF Wrestling star Sgt. Slaughter, Pete Rose, LL Cool J, Dan Quayle, Meatloaf, and Lesley Visser are also among the 130 celebrities slated to attend. The celebrity tournament closes out on February 20th with an awards ceremony.
The Football Network is an integrated multimedia company superserving football enthusiasts by connecting them to the sport via any and all means, including at present the Web and radio and in the future via cable/satellite TV and broadband. For more information, please visit our Website - footballnetwork.com or call us directly at 888-404-TDTV.
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such forward-looking statements involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.
The Football Network, Los Angeles
Tawny White, 323/898-8388; E-MAIL, TawnywithTFN@aol.com
|RecommendKeepReplyMark as Last ReadRead Replies (2)|
|To: TokyoMex who wrote ()||2/13/2000 6:20:00 AM|
ACIT has doubled in a month|
and has lots more to go. Co. went public a few yrs. ago at $6 and fell to .25. Last 3 quarters have been profitable and next one will be too. Stock has been moving up to a little over $1.50 in the last month and I think this one will be back to $6 in the next 9 - 12 months. Low risk, high reward play. Buyers have been accumulating anticipating the break.
|RecommendKeepReplyMark as Last Read|
|To: TokyoMex who wrote ()||2/14/2000 9:58:00 AM|
RGEN - FDA approval today - One of a kind drug.|
Monday February 14, 6:45 am Eastern Time
Company Press Release
SOURCE: Repligen Corporation
Repligen Issued Broad U.S. Patent For Use of Secretin In The Treatment of Autism
NEEDHAM, Mass., Feb. 14 /PRNewswire/ -- Repligen Corporation (Nasdaq: RGEN - news) today announced it was awarded a U.S. patent for the use of secretin in the treatment of autism spectrum disorder and its symptoms. U.S. patent No. 6,020,310 is entitled ``Method for assisting in differential diagnosis and treatment of autistic syndromes.'
The patent, which will remain in force until 2018, covers intravenous administration of secretin for the treatment of autism spectrum disorder and its symptoms, as well as methods where secretin is co-administered with a permeation-enhancing agent.
In March 1999, Repligen acquired exclusive rights to a series of patent applications for the use of secretin, a naturally-occurring hormone currently approved to diagnose certain gastrointestinal conditions, as a potential autism therapy. Some autistic children who have received the hormone therapeutically have made improvements in social behavior, communication, gastrointestinal function and sleep. Repligen is developing a human synthetic form of secretin for evaluation in clinical trials in pediatric autism.
``This patent allowance gives us a strong proprietary position with regard to secretin as a potential new treatment for autism, a pervasive and debilitating developmental disorder for which there are no FDA approved treatments currently available,' said Walter C. Herlihy, Ph.D., President and CEO of Repligen. ``We are currently prosecuting additional patent applications in the United States and Europe to further strengthen our position.'
The patent also discloses a previously unrecognized relationship between the response of the pancreas to secretin stimulation and autism. A recent study published in the Journal of Pediatrics (Horvath et al, Journal of Pediatrics 135 (5): 559-63) showed that 75% of autistic children with gastrointestinal symptoms had a significantly greater pancreatic response to secretin compared to children without the disorder, suggesting lack of normal secretin stimulation in this subset of autistic patients. Conducted at the University of Maryland Medical Center, the study was designed to understand the underlying biology of secretin in autism.
Autism is a neurological disorder that typically appears during the first three years of life and is characterized by defects in social interaction, communication and abnormal behavior. It is the third most common developmental disability in the United States today, affecting at least half-a-million people. There is no FDA-approved treatment for autism.
Repligen Corporation develops new drugs for autism, organ transplant and cancer. Repligen also manufactures and markets a set of patented products based on Protein A, which are used by the pharmaceutical industry to produce therapeutic antibodies. Its corporate headquarters are located at 117 Fourth Avenue, Needham MA, 02494. Additional information may be requested from www.repligen.com.
|RecommendKeepReplyMark as Last ReadRead Replies (1)|